Stay updated on Ramucirumab+Pembrolizumab in Recurrent Head & Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Ramucirumab+Pembrolizumab in Recurrent Head & Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ramucirumab+Pembrolizumab in Recurrent Head & Neck Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page now displays that the study is no longer enrolling participants and that results have been submitted. It also adds new navigation/help items (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment label (from 'Intervention / Treatment' to 'Intervention/Treatment') with a revision tag updated to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-12T16:59:53.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The study record now displays Revision: v3.5.5, replacing Revision: v3.5.4, signaling a small update to the page data. This appears to be an administrative update rather than a change to study content or outcomes.
    Difference
    0.1%
    Check dated 2026-06-05T16:00:42.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Entries were added to the Study Record Dates section to capture the latest submission and posting dates, as well as a completion date. These updates reflect the current activity and status of the study record.
    Difference
    0.3%
    Check dated 2026-05-22T09:50:01.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision metadata on the page was updated from v3.5.3 to v3.5.4, reflecting a routine update to the page version.
    Difference
    0.1%
    Check dated 2026-05-15T06:28:11.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The study status is updated to Completed with a completion date of 2026-04-30 and a last update date of 2026-05-01, and the previous 'Active, not recruiting' status has been removed.
    Difference
    0.5%
    Check dated 2026-05-08T10:00:51.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The page’s interface/build version was updated from v3.5.2 to v3.5.3 without changing the displayed study details.
    Difference
    0.1%
    Check dated 2026-04-24T06:39:48.000Z thumbnail image

Stay in the know with updates to Ramucirumab+Pembrolizumab in Recurrent Head & Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ramucirumab+Pembrolizumab in Recurrent Head & Neck Cancer Clinical Trial page.